The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy Investigator Initiated Trial.

Trial Profile

The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy Investigator Initiated Trial.

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 26 Mar 2018

At a glance

  • Drugs Clevidipine (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Mar 2018 Status changed from recruiting to withdrawn prior to enrolment.
    • 18 Jun 2012 Planned end date changed from 1 Jul 2011 to 1 Jul 2013 as reported by ClinicalTrials.gov.
    • 26 Jul 2010 Planned end date changed from 1 Mar 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top